Moffitt Cancer Center researchers created machine learning models that use patient-reported outcomes and wearable data to predict urgent care visits for non-small cell lung cancer patients.
Key Details
- 1Machine learning models incorporated wearable sensor data (Fitbit) and quality-of-life surveys from 58 non–small cell lung cancer patients.
- 2Models using patient-reported and wearable data outperformed those using only clinical/demographic data in predicting urgent care visits during systemic therapy.
- 3Researchers employed explainable Bayesian Networks, revealing how symptom, sleep, and lab data affect risk.
- 4Study highlights potential to proactively intervene and prevent hospitalizations due to treatment complications.
- 5This was a single-center study with a modest sample; larger validation is planned.
Why It Matters
Integrating diverse patient-originated health data with explainable AI models could transform personalized cancer care by allowing real-time identification of high-risk patients and early intervention, potentially preventing costly or harmful acute events. Such approaches expand the role of AI in predictive analytics for oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.